EquityFlow › Companies › ExeVir Bio

ExeVir Bio

Biotech · BE · exevir.com

Clinical-stage biotech developing nanobody therapeutics for infectious diseases

Funding history

DateRoundAmount
Jan 2023Debt
ExeVir Bio raised EUR25M in venture debt from the European Investment Bank for its COVID-19 antibody therapeutic.
$25M

Investors

European Investment Bank

Similar companies in Biotech

ImperagenHaga BiosciencePixelgen TechnologiesGallantChai DiscoverySNIPR BiomeCellbox LabsScope BiosciencesGenLuminaActitheraNUCLIDIUMAnocca
Explore funding flow on EquityFlow →